Patent · US Active

Human iNKT cell activation using glycolipids

US9879042B2 · kind B2 · utility

10Cited by
189References
38Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 8, 2015
Grant dateJan 30, 2018
Priority date—
Expiry dateSep 8, 2035

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Glycosphingolipids (GSLs) compositions and methods for iNKT-independent induction of chemokines are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.